Advertisement

Journal of General Internal Medicine

, Volume 34, Issue 12, pp 2740–2748 | Cite as

The Medicare Shared Savings Program and Outcomes for Ischemic Stroke Patients: a Retrospective Cohort Study

  • Brystana G. KaufmanEmail author
  • Emily C. O’Brien
  • Sally C. Stearns
  • Roland Matsouaka
  • G. Mark Holmes
  • Morris Weinberger
  • Paula H. Song
  • Lee H. Schwamm
  • Eric E. Smith
  • Gregg C. Fonarow
  • Ying Xian
Original Research

Abstract

Background

Post-stroke care delivery may be affected by provider participation in Medicare Shared Savings Program (MSSP) Accountable Care Organizations (ACOs) through systematic changes to discharge planning, care coordination, and transitional care.

Objective

To evaluate the association of MSSP with patient outcomes in the year following hospitalization for ischemic stroke.

Design

Retrospective cohort

Setting

Get With The Guidelines (GWTG)–Stroke (2010–2014)

Participants

Hospitalizations for mild to moderate incident ischemic stroke were linked with Medicare claims for fee-for-service beneficiaries ≥ 65 years (N = 251,605).

Main Measures

Outcomes included discharge to home, 30-day all-cause readmission, length of index hospital stay, days in the community (home-time) at 1 year, and 1-year recurrent stroke and mortality. A difference-in-differences design was used to compare outcomes before and after hospital MSSP implementation for patients (1) discharged from hospitals that chose to participate versus not participate in MSSP or (2) assigned to an MSSP ACO versus not or both. Unique estimates for 2013 and 2014 ACOs were generated.

Key Results

For hospitals joining MSSP in 2013 or 2014, the probability of discharge to home decreased by 2.57 (95% confidence intervals (CI) = − 4.43, − 0.71) percentage points (pp) and 1.84 pp (CI = − 3.31, − 0.37), respectively, among beneficiaries not assigned to an MSSP ACO. Among discharges from hospitals joining MSSP in 2013, beneficiary ACO alignment versus not was associated with increased home discharge, reduced length of stay, and increased home-time. For patients discharged from hospitals joining MSSP in 2014, ACO alignment was not associated with changes in utilization. No association between MSSP and recurrent stroke or mortality was observed.

Conclusions

Among patients with mild to moderate ischemic stroke, meaningful reductions in acute care utilization were observed only for ACO-aligned beneficiaries who were also discharged from a hospital initiating MSSP in 2013. Only 1 year of data was available for the 2014 MSSP cohort, and these early results suggest further study is warranted.

Registration

None

KEY WORDS

health policy health services research Medicare stroke utilization outcomes 

Notes

Funding

Internal funding for this study was provided by the Duke Clinical Research Institute. The GWTG–Stroke program is currently supported in part by a charitable contribution from Bristol-Myers Squibb/Sanofi Pharmaceutical Partnership and the American Heart Association Pharmaceutical Roundtable. GWTG–Stroke has been funded in the past through support from Boehringer-Ingelheim and Merck.

Compliance with Ethical Standards

Conflict of Interest

ECO: Research grants from BMS, Novartis, Janssen, and GSK

GCF: Research Patient Centered Outcomes Research Institute, Consultant to Janssen

YX: Research funding from the American Heart Association, Daiichi Sankyo, Janssen Pharmaceuticals, and Genentech. Honorarium from Brain Canada

All remaining authors declare that they do not have a conflict of interest.

Supplementary material

11606_2019_5283_MOESM1_ESM.docx (74 kb)
ESM 1 (DOCX 73 kb)

References

  1. 1.
    McClellan M, Saunders R. Growth Of ACOs And Alternative Payment Models In 2017. Health Affairs Blog. http://www.healthaffairs.org/do/10.1377/hblog20170628.060719/full/. Published 2017. Accessed July 1, 2019.
  2. 2.
    Muhlestein D, McClellan M. Accountable Care Organizations In 2016: Private And Public-Sector Growth And Dispersion. http://healthaffairs.org/blog/2016/04/21/accountable-care-organizations-in-2016-private-and-public-sector-growth-and-dispersion/. Published 2016. July 1, 2019.
  3. 3.
    Muhlestein D, Gardner P, William C, de Lisle K. Projected Growth of Accountable Care Organizations. https://leavittpartners.com/whitepaper/projected-growth-of-accountable-care-organizations/ Leavitt Partners 2015. Accessed July 1, 2019.
  4. 4.
    McClellan M, McKethan AN, Lewis JL, Roski J, Fisher ES. A national strategy to put accountable care into practice. Health Aff (Millwood). 2010;29(5):982–990.CrossRefGoogle Scholar
  5. 5.
    Fisher ES, Shortell SM, Kreindler SA, Van Citters AD, Larson BK. A framework for evaluating the formation, implementation, and performance of accountable care organizations. Health Aff (Millwood). 2012;31(11):2368–2378.CrossRefGoogle Scholar
  6. 6.
    Marcoux RM, Larrat EP, Vogenberg FR. Accountable Care Organizations: An Improvement Over HMOs? P T. 2012;37(11):629–650.PubMedPubMedCentralGoogle Scholar
  7. 7.
    Burwell SM. Setting value-based payment goals--HHS efforts to improve U.S. health care. N Engl J Med. 2015;372(10):897–899.CrossRefGoogle Scholar
  8. 8.
    Tai W, Kalanithi L, Milstein A. What can be achieved by redesigning stroke care for a value-based world? Expert Rev Pharmacoecon Outcomes Res. 2014;14(5):585–587.CrossRefGoogle Scholar
  9. 9.
    Johnson BH, Bonafede MM, Watson C. Short- and longer-term health-care resource utilization and costs associated with acute ischemic stroke. Clinicoecon Outcomes Res. 2016;8:53–61.CrossRefGoogle Scholar
  10. 10.
    Lichtman JH, Leifheit-Limson EC, Jones SB, Wang Y, Goldstein LB. Preventable readmissions within 30 days of ischemic stroke among Medicare beneficiaries. Stroke. 2013;44(12):3429–3435.CrossRefGoogle Scholar
  11. 11.
    Tsai JP, Rochon PA, Raptis S, Bronskill SE, Bell CM, Saposnik G. A prescription at discharge improves long-term adherence for secondary stroke prevention. J Stroke Cerebrovasc Dis. 2014;23(9):2308–2315.CrossRefGoogle Scholar
  12. 12.
    Thrift AG, Kim J, Douzmanian V, et al. Discharge is a critical time to influence 10-year use of secondary prevention therapies for stroke. Stroke. 2014;45(2):539–544.CrossRefGoogle Scholar
  13. 13.
    Bushnell CD, Olson DM, Zhao X, et al. Secondary preventive medication persistence and adherence 1 year after stroke. Neurology. 2011;77(12):1182–1190.CrossRefGoogle Scholar
  14. 14.
    Burke JP, Sander S, Shah H, Zarotsky V, Henk H. Impact of persistence with antiplatelet therapy on recurrent ischemic stroke and predictors of nonpersistence among ischemic stroke survivors. Curr Med Res Opin. 2010;26(5):1023–1030.CrossRefGoogle Scholar
  15. 15.
    Prvu Bettger J, Alexander KP, Dolor RJ, et al. Transitional care after hospitalization for acute stroke or myocardial infarction: a systematic review. Ann Intern Med. 2012;157(6):407–416.CrossRefGoogle Scholar
  16. 16.
    Olson DM, Bettger JP, Alexander KP, et al. Transition of care for acute stroke and myocardial infarction patients: from hospitalization to rehabilitation, recovery, and secondary prevention. Evid Rep Technol Assess (Full Rep). 2011(202):1–197.Google Scholar
  17. 17.
    Hohmann C, Neumann-Haefelin T, Klotz JM, Freidank A, Radziwill R. Adherence to hospital discharge medication in patients with ischemic stroke: a prospective, interventional 2-phase study. Stroke. 2013;44(2):522–524.CrossRefGoogle Scholar
  18. 18.
    Brummel A, Lustig A, Westrich K, et al. Best practices: improving patient outcomes and costs in an ACO through comprehensive medication therapy management. J Manag Care Spec Pharm. 2014;20(12):1152–1158.PubMedGoogle Scholar
  19. 19.
    Lewis VA, Tierney KI, Fraze T, Murray GF. Care Transformation Strategies and Approaches of Accountable Care Organizations. Med Care Res Rev. 2017 1077558717737841.Google Scholar
  20. 20.
    Hammill BG, Hernandez AF, Peterson ED, Fonarow GC, Schulman KA, Curtis LH. Linking Inpatient Clinical Registry Data to Medicare Claims Data Using Indirect Identifiers. Am Heart J. 2009;157(6):995–1000.CrossRefGoogle Scholar
  21. 21.
    Singh GK. Area Deprivation and Widening Inequalities in US Mortality, 1969–1998. In: Am J Public Health. Vol 93.2003:1137–1143.CrossRefGoogle Scholar
  22. 22.
    Smith EE, Shobha N, Dai D, et al. Risk score for in-hospital ischemic stroke mortality derived and validated within the Get With the Guidelines-Stroke Program. Circulation. 2010;122(15):1496–1504.CrossRefGoogle Scholar
  23. 23.
    Christensen EW, Payne NR. Effect of Attribution Length on the Use and Cost of Health Care for a Pediatric Medicaid Accountable Care Organization. JAMA Pediatr. 2016;170(2):148–154.CrossRefGoogle Scholar
  24. 24.
    Myles PS, Shulman MA, Heritier S, et al. Validation of days at home as an outcome measure after surgery: a prospective cohort study in Australia. BMJ Open. 2018.7(8):e015828. doi:  https://doi.org/10.1136/bmjopen-2017-015828 CrossRefGoogle Scholar
  25. 25.
    Kumamaru H, Judd SE, Curtis JR, et al. Validity of claims-based stroke algorithms in contemporary Medicare data: reasons for geographic and racial differences in stroke (REGARDS) study linked with medicare claims. Circ Cardiovasc Qual Outcomes. 2014;7(4):611–619.CrossRefGoogle Scholar
  26. 26.
    Hartmann A, Rundek T, Mast H, et al. Mortality and causes of death after first ischemic stroke: the Northern Manhattan Stroke Study. Neurology. 2001;57(11):2000–2005.CrossRefGoogle Scholar
  27. 27.
    Levey AS, Stevens LA, Schmid CH, et al. A New Equation to Estimate Glomerular Filtration Rate. Ann Intern Med. 2009;150(9):604–612.CrossRefGoogle Scholar
  28. 28.
    Colla CH, Lewis VA, Kao LS, O’Malley AJ, Chang CH, Fisher ES. Association Between Medicare Accountable Care Organization Implementation and Spending Among Clinically Vulnerable Beneficiaries. JAMA Intern Med. 2016;176(8):1167–1175.CrossRefGoogle Scholar
  29. 29.
    Huskamp HA, Greenfield SF, Stuart EA, et al. Effects of Global Payment and Accountable Care on Tobacco Cessation Service Use: An Observational Study. J Gen Intern Med. 2016;31(10):1134–1140.CrossRefGoogle Scholar
  30. 30.
    Liu Y, De A. Multiple Imputation by Fully Conditional Specification for Dealing with Missing Data in a Large Epidemiologic Study. Int J Stat Med Res. 2015;4(3):287–295.CrossRefGoogle Scholar
  31. 31.
    Nyweide DJ, Lee W, Cuerdon TT, et al. Association of Pioneer Accountable Care Organizations vs traditional Medicare fee for service with spending, utilization, and patient experience. Jama. 2015;313(21):2152–2161.CrossRefGoogle Scholar
  32. 32.
    Rosenthal MB, Landrum MB, Robbins JA, Schneider EC. Pay for Performance in Medicaid: Evidence from Three Natural Experiments. Health Serv Res. 2016;51(4):1444–1466.CrossRefGoogle Scholar
  33. 33.
    Kautter J, Pope GC, Leung M, et al. Evaluation of the Medicare Physician Group Practice Demonstration: Final Report. Research Triangle Park, North Carolina: RTI International, Inc;2012.Google Scholar
  34. 34.
    McWilliams JM, Hatfield LA, Chernew ME, Landon BE, Schwartz AL. Early Performance of Accountable Care Organizations in Medicare. N Engl J Med. 2016;374(24):2357–2366.CrossRefGoogle Scholar
  35. 35.
    Schwartz AL, Chernew ME, Landon BE, McWilliams JM. Changes in Low-Value Services in Year 1 of the Medicare Pioneer Accountable Care Organization Program. JAMA Intern Med. 2015;175(11):1815–1825.CrossRefGoogle Scholar
  36. 36.
    O’Brien EC, Xian Y, Xu H, et al. Hospital Variation in Home-Time After Acute Ischemic Stroke: Insights From the PROSPER Study (Patient-Centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research). Stroke. 2016;47(10):2627–2633.CrossRefGoogle Scholar
  37. 37.
    Young JQ, Ranji SR, Wachter RM, Lee CM, Niehaus B, Auerbach AD. “July effect”: impact of the academic year-end changeover on patient outcomes: a systematic review. Ann Intern Med. 2011;155(5):309–315.CrossRefGoogle Scholar
  38. 38.
    Centers for Medicare and Medicaid Services. Medicare Accountable Care Organizations 2015 Performance Year Quality and Financial Results. https://www.cms.gov/newsroom/fact-sheets/medicare-accountable-care-organizations-2015-performance-year-quality-and-financial-results. Published 2016. Accessed July 1, 2019.
  39. 39.
    Kaufman BG, Spivack BS, Stearns SC, Song PH, O’Brien EC. Impact of Accountable Care Organizations on Utilization, Care, and Outcomes: A Systematic Review. Med Care Res Rev. 2017 1077558717745916.Google Scholar
  40. 40.
    McWilliams JM, Gilstrap LG, Stevenson DG, Chernew ME, Huskamp HA, Grabowski DC. Changes in Postacute Care in the Medicare Shared Savings Program. JAMA Intern Med. 2017;177(4):518–526.CrossRefGoogle Scholar
  41. 41.
    Winblad U, Mor V, McHugh JP, Rahman M. ACO-Affiliated Hospitals Reduced Rehospitalizations From Skilled Nursing Facilities Faster Than Other Hospitals. Health Aff (Millwood). 2017;36(1):67–73.CrossRefGoogle Scholar
  42. 42.
    Colla CH, Lewis VA, Kao LS, O’Malley AJ, Chang CH, Fisher ES. Notice of Retraction and Replacement: Colla et al. Association between Medicare accountable care organization implementation and spending among clinically vulnerable beneficiaries. JAMA Internal Medicine. 2016;176(8):1167–1175. JAMA Intern Med. 2017.CrossRefGoogle Scholar
  43. 43.
    Schoenfeld AJ, Sturgeon DJ, Blucher JA, Haider AH, Kang JD. Alterations in 90-Day Morbidity, Mortality and Readmission Rates Following Spine Surgery in Medicare Accountable Care Organizations (2009-2014). Spine J. 2018.Google Scholar
  44. 44.
    Colla CH, Lewis VA, Tierney E, Muhlestein DB. Hospitals Participating In ACOs Tend To Be Large And Urban, Allowing Access To Capital And Data. Health Aff (Millwood). 2016;35(3):431–439.CrossRefGoogle Scholar
  45. 45.
    Song S, Fonarow GC, Olson DM, et al. Association of Get With The Guidelines-Stroke Program Participation and Clinical Outcomes for Medicare Beneficiaries With Ischemic Stroke. Stroke. 2016;47(5):1294–1302.CrossRefGoogle Scholar
  46. 46.
    Alcusky M, Ulbrict CM, Lapane KL. Post-Acute Care Setting, Facility Characteristics, and Post-Stroke Outcomes: A Systematic Review. Arch Phys Med Rehabil. 2017.Google Scholar
  47. 47.
    Fang MC, Perraillon MC, Ghosh K, Cutler DM, Rosen AB. Trends in Stroke Rates, Risk, and Outcomes in the United States, 1988–2008. Am J Med. 2014;127(7):608–615.CrossRefGoogle Scholar
  48. 48.
    McWilliams JM, Chernew ME, Landon BE. Medicare ACO Program Savings Not Tied To Preventable Hospitalizations Or Concentrated Among High-Risk Patients. Health Affairs. 2017: 36(12)  https://doi.org/10.1377/hlthaff20170814.
  49. 49.
    RTI International. Accountable Care Organization 2014 Program Analysis Quality Performance Standards Narrative Measure Specifications. Report for Centers for Medicare & Medicaid Services. 2014. https://www.healthreform.ct.gov/ohri/lib/ohri/work_groups/quality/2014-09-03/aco_narrative_measures_specs_1.pdf. Accessed July 1, 2019.
  50. 50.
    Centers for Medicare & Medicaid Services. Quality Measure Benchmarks for the 2016 and 2017 Reporting Years. https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/sharedsavingsprogram/Downloads/MSSP-QM-Benchmarks-2016.pdf. Published 2016. Accessed July 1, 2019.
  51. 51.
    Reeves MJ, Fonarow GC, Smith EE, et al. Representativeness of the Get With The Guidelines-Stroke Registry: comparison of patient and hospital characteristics among Medicare beneficiaries hospitalized with ischemic stroke. Stroke. 2012;43(1):44–49.CrossRefGoogle Scholar

Copyright information

© Society of General Internal Medicine 2019

Authors and Affiliations

  • Brystana G. Kaufman
    • 1
    • 2
    Email author
  • Emily C. O’Brien
    • 2
  • Sally C. Stearns
    • 1
    • 3
  • Roland Matsouaka
    • 4
  • G. Mark Holmes
    • 1
    • 3
  • Morris Weinberger
    • 1
  • Paula H. Song
    • 1
    • 3
  • Lee H. Schwamm
    • 5
    • 6
  • Eric E. Smith
    • 7
  • Gregg C. Fonarow
    • 8
  • Ying Xian
    • 4
  1. 1.Department of Health Policy and ManagementUniversity of North Carolina at Chapel HillChapel HillUSA
  2. 2.Department of Population Health Sciences Duke UniversityDurhamUSA
  3. 3.The Cecil G. Sheps Center for Health Services ResearchUniversity of North Carolina at Chapel HillChapel HillUSA
  4. 4.Duke Clinical Research InstituteDurhamUSA
  5. 5.NeurologyMassachusetts General HospitalBostonUSA
  6. 6.Harvard Medical SchoolBostonUSA
  7. 7.Department of Clinical Neurosciences, Cumming School of MedicineUniversity of CalgaryCalgaryCanada
  8. 8.CardiologyDavid Geffen School of Medicine at UCLALos AngelesUSA

Personalised recommendations